Propofol-Induced Hyperglycemia in Critically Ill Patients
Author Information
Author(s): Muacevic Alexander, Adler John R, Qureshi Muhammad A, Thomas Greeshma A, Mathew Tijin, Anshul FNU
Primary Institution: Southeast Health Medical Center, Dothan, USA
Hypothesis
Does propofol cause hyperglycemia in critically ill patients?
Conclusion
Propofol can induce hyperglycemia in critically ill patients, impacting their treatment and outcomes.
Supporting Evidence
- Propofol is commonly used in the ICU and may lead to hyperglycemia.
- Animal studies suggest propofol induces insulin resistance.
- The patient's blood glucose spiked after starting propofol sedation.
- Discontinuation of propofol led to improved blood glucose levels.
Takeaway
When doctors use a common sedative called propofol in very sick patients, it can make their blood sugar go too high, which is not good for them.
Methodology
Case report of a 58-year-old female patient with hyperglycemia after receiving propofol for sedation.
Potential Biases
Limited evidence from human studies may introduce bias in understanding the effects of propofol.
Limitations
The study is based on a single case and lacks extensive human trials.
Participant Demographics
One 58-year-old female patient with a history of diabetes and other health issues.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website